首页> 外文OA文献 >The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers

【2h】

The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers

机译：SV40大T抗原的N末端结构域抑制乳腺癌中HER2 / neu介导的转化和转移潜能

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chuang Tzu-Chao; Yu Yuh-Hua; Lin Yen-Shing; Wang Shan-Shue; Kao Ming-Ching;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The N‐terminal domain of SV40 large T antigen represses the HER2eu‐mediated transformation and metastatic potential in breast cancers [J] . Chuang Tzu-Chao, Kao Ming-Ching, Lin Yen-Shing, FEBS Letters . 2002,第1a3期

机译：SV40大T抗原的N末端结构域抑制乳腺癌中HER2 / neu介导的转化和转移潜能
2. Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study [J] . Tryfonidis Konstantinos, Marreaud S., Khaled H., Breast cancer research and treatment. . 2017,第3期

机译：连续血清Her2-细胞外结构域脱落抗原测量的心脏安全性，疗效和相关性与HER2阳性转移乳腺癌妇女组合的曲妥珠单抗加上CMF的结果：来自EORTC 10995期II研究的结果
3. SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS [J] . Kurbacher Christian Martin, Quade Annegret, Kunstmann Gerhard, The Breast : . 2015,第Suppla3期

机译：成功使用HER2阴性的转移性乳腺癌较重治疗的HER2阴性乳腺癌患者，如果其血清水平升高且HER2胞外域水平升高和/或HER2过度表达循环肿瘤细胞，则可成功使用HER2靶向剂
4. The Cancer Preventive Potential of Tea Polyphenol EGCG in HER2-Positive Breast Cancer [C] . Min-Hsiung Pan, Wei-Jen Chen Functional food and health . 2006

机译：茶多酚EGCG对HER2阳性乳腺癌的预防作用。
5. Boron Neutron Capture Therapy for HER2+ breast cancers: A feasibility study evaluating BNCT for potential role in breast conservation therapies. [D] . Jenkins, Peter Anthony. 2012

机译：HER2 +乳腺癌的硼中子捕获疗法：评估BNCT在乳腺癌保护疗法中潜在作用的可行性研究。
6. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer [O] . M. J. Hoenerhoff, M. A. Shibata, A. Bode, -1

机译：乳腺癌的C3（1）/ SV40 T / T抗原转基因大鼠模型的病理进展性三重阴性和HER2阳性乳腺癌
7. Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer [O] . Elisa Van Raemdonck, G. Floris, P. Berteloot, 2020

机译：抗HER2治疗在原发性和转移性乳腺癌之间的表达中的一种抗乳腺癌患者的疗效
8. Effects of Csk Homologous Kinase Overexpression on HER2/Neu-Mediated Signal Transduction Pathways in Breast Cancer Cells. [R] . Zagozdzon, R., Avraham, H. 2005

机译：Csk同源激酶过表达对乳腺癌细胞HER2 / Neu介导的信号转导通路的影响。

The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers

著录项

引文网络

相似文献

相关主题

期刊订阅